Literature DB >> 34505944

Characterizing DRESS syndrome recurrence: a systematic review.

Ajay N Sharma1, Samantha Shwe1, Vignesh Ravi2, Melanie Miller2, Natasha A Mesinkovska1, Nathan W Rojek1, Scott Worswick3.   

Abstract

Recurrence of DRESS syndrome is poorly characterized, and dermatologists must be prepared to predict, identify, and manage patients after treatment of the initial presentation. In this study, a primary literature search was conducted using PubMed, capturing all articles recording cases of DRESS syndrome recurrence. Forty-two articles were included for review comprising a total of 60 patients. The average age of patients was 46.3 years and time to recurrence was 123 days. Recurrent episodes presented more frequently with a higher fever and eosinophil absolute peak. Relapse was most often attributed to the introduction of a new medication (n = 18). Of the 17 cases in which outcome data were available, the survival rate of those experiencing recurrence was 71%. Viral reactivation with HHV-6 and organ involvement of the liver were frequently recorded complications. In essence, viral reactivation, severe internal organ involvement, and hematological abnormalities all portended a poorer prognosis in those experiencing DRESS syndrome recurrence. An adequate course of treatment should be maintained until clinical and laboratory parameters normalize, with a slow taper to minimize the likelihood of relapse in those most at risk.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  DRESS; Drug hypersensitivity reaction; Drug reaction with eosinophilia and systemic symptoms; Eosinophilia; Inpatient; Recurrence

Mesh:

Year:  2021        PMID: 34505944     DOI: 10.1007/s00403-021-02274-3

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.033


  44 in total

1.  Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome.

Authors:  Sonal Choudhary; Michael McLeod; Daniele Torchia; Paolo Romanelli
Journal:  J Clin Aesthet Dermatol       Date:  2013-06

2.  Ethosuximide-induced drug reaction with eosinophilia and systemic symptoms with mediastinal lymphadenopathy.

Authors:  Tyler Werbel; Philip Castrovinci; James Contestable
Journal:  Pediatr Dermatol       Date:  2019-05-27       Impact factor: 1.588

3.  Skeletal myositis as the sole feature of relapsing drug reaction with eosinophilia and systemic symptoms syndrome.

Authors:  Jennifer Massey; Kishore Kumar; Karl Ng; James Yun; Suran Fernando
Journal:  Ann Allergy Asthma Immunol       Date:  2017-04-19       Impact factor: 6.347

Review 4.  Drug-induced pseudolymphoma and drug hypersensitivity syndrome (Drug Rash with Eosinophilia and Systemic Symptoms: DRESS).

Authors:  H Bocquet; M Bagot; J C Roujeau
Journal:  Semin Cutan Med Surg       Date:  1996-12

Review 5.  Drug reaction with Eosinophilia and Systemic Symptoms (DRESS) / Drug-induced Hypersensitivity Syndrome (DIHS): a review of current concepts.

Authors:  Paulo Ricardo Criado; Roberta Fachini Jardim Criado; João de Magalhães Avancini; Claudia Giuli Santi
Journal:  An Bras Dermatol       Date:  2012 May-Jun       Impact factor: 1.896

6.  Exacerbation of allopurinol-induced drug reaction with eosinophilia and systemic symptoms by teicoplanin: A case report.

Authors:  H Taghvaye Masoumi; M Hadjibabaie; M Zarif-Yeganeh; O Arasteh
Journal:  J Clin Pharm Ther       Date:  2017-05-29       Impact factor: 2.512

7.  [Sulfasalazine-induced hypersensitivity syndrome associated with human herpesvirus 6 reactivation and induction of antiphospholipid syndrome].

Authors:  Y Tung; B Escutia; M Blanes; M Navarrro; C Pujol
Journal:  Actas Dermosifiliogr       Date:  2011-03-23

8.  Flare-up reactions in severe drug hypersensitivity: infection or ongoing T-cell hyperresponsiveness.

Authors:  Lukas Jörg-Walther; Benno Schnyder; Arthur Helbling; Karin Helsing; Alexandra Schüller; Annette Wochner; Werner Pichler
Journal:  Clin Case Rep       Date:  2015-08-26

9.  Successful treatment of drug reaction with eosinophilia and systemic symptoms syndrome relapse with oral pulsed dexamethasone.

Authors:  Claire-Audrey Y Bayan; Adriana Lopez; Natalia M Fontecilla; Larisa J Geskin
Journal:  JAAD Case Rep       Date:  2018-10-13

10.  Altered T cell and monocyte subsets in prolonged immune reconstitution inflammatory syndrome related with DRESS (drug reaction with eosinophilia and systemic symptoms).

Authors:  Sung-Yoon Kang; Jihyun Kim; Jongho Ham; Sang-Heon Cho; Hye-Ryun Kang; Hye Young Kim
Journal:  Asia Pac Allergy       Date:  2020-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.